Expression of the DCC Gene in Human Hematological Malignancies

References

• Weinberg R. A. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res. 1989; 49: 3713–3721
   PubMed Web of Science ®Google Scholar
• Fearon E. R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759–767
   PubMed Web of Science ®Google Scholar
• Stanbridge E. J. Identifying tumor suppressor genes in human colorectal cancer. Science 1990; 247: 12–13
   PubMed Web of Science ®Google Scholar
• Thomas G., Delattre O., Olschwang S., Laurent-Puig P. Inherited and acquired genetic alterations in human colorectal cancer. Cancer J. 1990; 3: 304–309
   Google Scholar
• Goyette M. C., Cho K., Fasching C. L., Levy D. B., Kinzler K. W., Paraskeva C., Vogelstein B., Stan-bridge E. J. Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol. Cell. Biol. 1992; 12: 1387–1395
   PubMed Web of Science ®Google Scholar
• Slingerland J. M., Minden M. D., Benchimol S. Mutation of the p53 gene in human acute myelogenous leukemia. Blood 1991; 77: 1500–1507
   PubMed Web of Science ®Google Scholar
• Fenaux P., Jonveaux P., Quiquandon I., Lai J. L., Pignon M., Loucheux-Lefebvre M. H., Bauters F., Berger R., Kerckaert J. P. P53 gene mutations in acute myeloid leukemia with 17p monosomy. Blood 1991; 78: 1652–1657
   PubMed Web of Science ®Google Scholar
• Sugimoto K., Toyoshima H., Sakai R., Miyagawa K., Hagiwara K., Hirai H., Ishikawa F., Takaku F. Mutations of the p53 gene in lymphoid leukemia. Blood 1991; 77: 1153–1156
   PubMed Web of Science ®Google Scholar
• Gaidano G., Ballerini P., Gong J. Z., Inghirami G., Neri A., Newcomb E. W., Magrath I. T., Knowles D. M., Dalla-Favera R. p53 mutation in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 1991; 88: 5413–5417
   PubMed Web of Science ®Google Scholar
• Ahuja H., Bar-Eli M., Advani S. H., Benchimol S., Cline M. J. Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Proc. Nail. Acad. Sci. USA. 1989; 86: 6783–6787
   PubMed Web of Science ®Google Scholar
• Kelman Z., Prokocimer M., Peller S., Kahn Y., Rechavi G., Manor Y., Cohen A., Rotter V. Rearrangements in the p53 gene in Philadelphia chromosome positive chronic myelogenous leukemia. Blood 1989; 74: 2318–2324
   PubMed Web of Science ®Google Scholar
• Mashal R., Shtalrid M., Talpaz M., Kantarjian H., Smith L., Beran M., Cork A., Trujillo J., Gutterman J., Deisseroth A. Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemia. Blood 1990; 75: 180–189
   PubMed Web of Science ®Google Scholar
• Ahuja H., Bar-Eli M., Arlin Z., Advani S., Allen S. L., Goldman J., Snyder D., Foti A., Cline M. The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia. J. Clin. Invest. 1991; 87: 2042–2047
   PubMed Web of Science ®Google Scholar
• Sakashita A., Hattori T., Miller C. W., Suzushima H., Asou N., Takatsuki K., Koeffler H. P. Mutation of the p53 gene in adult T-cell leukemia. Blood 1992; 79: 477–480
   PubMed Web of Science ®Google Scholar
• Cesarman E., Chadburn A., Inghirami G., Gaidano G., Knowles M. adult T-Cell leukemia/lymphoma shows frequent p53 Mutations. Blood 1992; 80: 3205–3216
   PubMed Web of Science ®Google Scholar
• Cheng J., Scully P., Shew J. Y., Lee W. H., Vila V., Haas M. Homozygous deletion of the retinoblastoma gene in an acute lymphoblastic leukemia (T) cell line. Blood 1990; 75: 730–735
   PubMed Web of Science ®Google Scholar
• Chen Y. C., Chen P. J., Yeh S. H., Tien H. F., Wang C. H., Tang J. L., Hong R. L. Deletion of the human retinoblastoma gene in primary leukemias. Blood 1990; 76: 2060–2064
   PubMed Web of Science ®Google Scholar
• Ginsberg A. M., Raffeld M., Cossman J. In-activation of the retinoblastoma gene in human lymphoid neoplasms. Blood 1991; 77: 833–840
   PubMed Web of Science ®Google Scholar
• Towatari M., Adachi K., Kato H., Saito H. Absence of the human retinoblastoma gene product in the megakaryoblastic crisis of chronic myelogenous leukemia. Blood 1991; 78: 2178–2181
   PubMed Web of Science ®Google Scholar
• Ahuja H. G., Jat P. S., Foti A., Bar-Eli M., Cline M. J. Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia. Blood 1991; 78: 3259–3268
   PubMed Web of Science ®Google Scholar
• Kornblau S. M., Xu J. H., del Giglio A., Hu S. X., Zhang W., Calvert S., Beran M., Estey E., Andreeff M., Trujillo J., Cork A., Smith T. L., Benedict W. F., Deisseroth A. Expression of retinoblastoma protein in newly diagnosed and relapsed acute myelogenous leukemia. Cancer Res. 1992; 52: 4587–4590
   PubMed Web of Science ®Google Scholar
• Kornblau S. M., Chen N., Giglio A., O'Brien S., Deisseroth A. B. Retinoblastoma protein expression is frequently altered in chronic lymphocytic leukemia. Cancer Res. 1994; 54: 242–246
   PubMed Web of Science ®Google Scholar
• Willman C. L., Sever C. E., Pallavicini M. G., Harada H., Tanaka N., Slovak M. L., Yamamoto H., Harada K., Meeker T. C., List A. F., Taniguchi T. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 1993; 259: 968–971
   PubMed Web of Science ®Google Scholar
• Boultwood J., Fidler C., Lewis S., MacCarthy A., Sheridan H., Kelly S., Oscier D., Buckle V. J., Wainscoat J. S. Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: Retention of IRF1 on the 5q-chromosome in some patients with the 5q-syndrome. Blood 1993; 82: 2611–2616
   PubMed Web of Science ®Google Scholar
• Fearon E. R., Cho K. R., Nigro J. M., Kern S. E., Simons J. W., Ruppert J. M., Hamilton S. R., Preisinger A. C., Thomas G., Kinzler K. W., Vogelstein B. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 1990; 247: 49–56
   PubMed Web of Science ®Google Scholar
• Hedrick L., Cho K. R., Boyd J., Risinger J., Vogelstein B. DCC: A tumor suppressor gene expressed on the cell surface. Cold Spring Harbor Symp. Quant. Biol. 1992; 57: 345–351
   PubMedGoogle Scholar
• Tanaka K., Oshimura M., Kikuchi R., Seki M., Hayashi T., Miyaki M. Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18. Nature 1991; 349: 340–342
   PubMed Web of Science ®Google Scholar
• Narayanan R., Lawlor K. G., Schaapveld R. Q. J., Cho K. R., Vogelstein B., Tran P. B. V., Osborne M. P., Telang N. T. Antisense RNA to the putative tumor-suppressor gene DCC transforms Rat-1 fibroblasts. Oncogene 1992; 7: 553–561
   PubMed Web of Science ®Google Scholar
• Kikuchi-Yanoshita R., Konishi M., Fukunari H., Tanaka K., Miyaki M. Loss of expression of the DCC gene during progression of colorectal carcinomas in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Res. 1992; 52: 3801–3805
   PubMed Web of Science ®Google Scholar
• Itoh F., Hinoda Y., Ohe M., Ohe Y., Ban T., Endo T., Imai K., Yachi A. Decreased expression of DCC mRNA in human colorectal cancers. Int. J. Cancer 1993; 53: 260–263
   PubMed Web of Science ®Google Scholar
• Ookawa K., Sakamoto M., Hirohashi S., Yosida Y., Sug-imura T., Terada M., Yokota J. Concordant p53 and DCC alterations and allelic losses on chromosomes 13q and 14q associated with liver metastases of colorectal carcinoma. Int. J. Cancer 1993; 53: 382–387
   PubMed Web of Science ®Google Scholar
• Uchino S., Tsuda H., Noguchi M., Yokota J., Terada M., Saito T., Kobayashi M., Sugimura T., Hirohashi S. Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res. 1992; 52: 3099–3102
   PubMed Web of Science ®Google Scholar
• Huang Y., Boynton R. F., Blount P. L., Silverstein R. J., Yin J., Tong Yi, McDaniel T. K., Newkirk C., Resau J. M., Sridhara R., Reid B. J., Meltzer S. J. Loss of heterozygosity involves multiple tumor suppressor gene in human esophageal cancers. Cancer. Res. 1992; 52: 6525–6530
   PubMed Web of Science ®Google Scholar
• Gao X., Honn K. V., Grignon D., Sakr W., Chen Y. Q. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res. 1993; 53: 2723–2727
   PubMed Web of Science ®Google Scholar
• Chenevix-Trench G., Leary J., Kerr J., Michel J., Kef-ford R., Hurst T., Parsons P. G., Friedlander M., Khoo S. K. Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus. Oncogene 1992; 7: 1059–1065
   PubMed Web of Science ®Google Scholar
• Devilee P., van Vliet M., Kuipers-Dijkshoorn N., Pearson P. L., Cornelisse C. J. Somatic genetics changes on chromosome 18 in breast carcinomas: is the DCC gene involved?. Oncogene 1991; 6: 311–315
   PubMed Web of Science ®Google Scholar
• Simons J. W., Oliner J. D., Cho K. R., Kinzler K. W., Vogelstein B. SAM 1.1 and JOSH4.5: two RFLPs within the human DCC gene. Human molecular Genetics 1992; 1: 352
   PubMedGoogle Scholar
• Miyake K., Inokuchi K., Dan K., Nomura T. Alterations in the deleted in colorectal carcinoma gene in human primary leukemia. Blood 1993; 82: 927–930
   PubMed Web of Science ®Google Scholar
• Nigra J. M., Cho K. R., Fearon E. R., Kern S. E., Rup-pert J. M., Oliner J. D., Kinzler K. W., Vogelstein B. Scrambled Exons. Cell 1991; 64: 607–613
   PubMed Web of Science ®Google Scholar
• Hohne M. W., Halatsh M. E., Kahl G. F., Weinel R. J. Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. Cancer Res. 1992; 52: 2616–2819
   PubMed Web of Science ®Google Scholar
• Scheck A. C., Coons S. W. Expression of the tumor suppressor gene DCC in human gliomas. Cancer Res. 1993; 53: 5605–5609
   PubMed Web of Science ®Google Scholar
• Porfiri E., Seeker-Walker L. M., Hoffbrand A. V., Hancock J. F. DCC tumor suppressor gene is inactivated in hematologic malignancies showing monosomy 18. Blood 1993; 81: 2696–2701
   PubMed Web of Science ®Google Scholar
• Abo J., Inokuchi K., Dan K., Nomura T. p53 and N-ras mutation in two new leukemia cell lines established from a patient with multilineage CD7-positive acute leukemia. Blood 1993; 82: 2829–2836
   PubMed Web of Science ®Google Scholar
• Koeffler H. P. Myelodysplastic syndromes (Preleukemia). Semin. Hematology 1986; 23: 284–299
   PubMed Web of Science ®Google Scholar
• Hirai H., Kobayashi Y., Mano H., Hagiwara K., Maru Y., Omine M., Mizoguchi H., Nishida J., Takaku F. A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome. Nature 1987; 327: 430–432
   PubMed Web of Science ®Google Scholar
• Liu E., Hjelle B., Morgan R., Hecht F., Bishop J. M. Mutations of Kirsten-ras proto-oncogene in human preleukemia. Nature 1987; 300: 186–188
   Web of Science ®Google Scholar
• Janssen J. W. G., Steenvoorden A. C. M., Lyons J., Anger B., Bohlke J. U., Bos J. L., Seliger H., Bartram C. R. Ras gene mutation in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes. Proc. Natl. Acad. Sci. USA 1987; 84: 9228–9232
   PubMed Web of Science ®Google Scholar
• Lyons J., Janssen J. W. G., Bartram C., Layton M., Mufti G. J. Mutation of Ki-ras and N-ras oncogene in myelodysplastic syndromes. Blood 1988; 71: 1707–1712
   PubMed Web of Science ®Google Scholar
• Padua R. A., Carter G., Hughes D., Gow J., Farr C., Oscier D., McCormick F., Jacobs A. RAS mutations in myelodysplasia detected by amplification, oligonucleotide hybridization, and transformation. Leukemia 1988; 2: 503–510
   PubMed Web of Science ®Google Scholar
• Yunis J. J., Boot A. J. M., Mayer M. G., Bos J. L. Mechanisms of ras mutation in myelodysplastic syndrome. Oncogene 1989; 4: 609–614
   PubMed Web of Science ®Google Scholar
• Ridge S. A., Worwood M., Oscier D., Jacobs A., Padua R. A. FMS mutations in myelodysplastic, leukemic, and normal subjects. Proc. Natl. Acad. Sci. USA 1990; 87: 1377–1380
   PubMed Web of Science ®Google Scholar
• Tobal K., Pagliuca A., Bhatt B., Bailey N., Layton D. M., Mufti G. J. Mutation of the FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemia. Leukemia 1990; 4: 486–489
   PubMed Web of Science ®Google Scholar
• Jonveaux Ph., Fenaux P., Quiquandon I., Pignon J. M., Lai J. L., Loucheux-Lefebvre M. H., Goossens M., Bau-ters F., Berger R. Mutations in the p53 gene in myelodysplastic syndromes. Oncogene 1991; 6: 2243–2247
   PubMed Web of Science ®Google Scholar
• Sugimoto K., Hirano N., Toyoshima H., Chiba S., Mano H., Takaku F., Yazaki Y., Hirai H. Mutation of the p53 gene in myelodysplastic syndrome (MDS) and MDS-Derived leukemia. Blood 1993; 81: 3022–3026
   PubMed Web of Science ®Google Scholar
• Miyake K., Inokuchi K., Dan K., Nomura T. Expression of the DCC gene in Myelodysplastic Syndromes and Overt Leukemia. Leuk. Res. 1993; 17: 785–788
   PubMed Web of Science ®Google Scholar